VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,767 | -2.5% | 318,591 | +1.6% | 0.03% | -25.7% |
| Q2 2023 | $219,207 | -95.2% | 313,677 | +37.2% | 0.04% | -96.6% |
| Q1 2023 | $4,591,834 | -61.4% | 228,677 | -49.8% | 1.04% | -63.7% |
| Q4 2022 | $11,892,573 | +6062.0% | 455,131 | +44.4% | 2.87% | +7450.0% |
| Q3 2022 | $193,000 | -3.5% | 315,131 | +5.0% | 0.04% | +5.6% |
| Q2 2022 | $200,000 | – | 300,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |